JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk

Autor:	Atsushi Hirayama, Norio Tanahashi, Michiya Tachiiri, Takanori Hayasaki
Rok vydání:	2022
Předmět:	Stroke Treatment Outcome Rivaroxaban Atrial Fibrillation Anticoagulants Humans Hemorrhage General Medicine Cardiology and Cardiovascular Medicine Factor Xa Inhibitors Retrospective Studies
Zdroj:	Circulation journal : official journal of the Japanese Circulation Society. 86(7)
ISSN:	1347-4820
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e89fb0d193fd3164a98dc923e02c6cc https://pubmed.ncbi.nlm.nih.gov/35644538 Zobrazit plný text záznamu